Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Endocyte Inc (ECYT)    
$7.36 0.38 (5.44%) as of 4:30 Fri 8/29


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 36,125,000 as of 6/30
Market Cap: 265.88(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.96 - $27.22
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:

      

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. Co. uses its technology to create small molecule drug conjugates (SMDCs), and companion imaging diagnostics. Co.'s SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. Co. is also developing vintafolide for use in non-small cell lung cancer.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,479 30,479 66,479 298,709
Total Sell Value $150,353 $436,393 $957,193 $4,038,012
Total People Sold 1 2 5 8
Total Sell Transactions 1 3 11 47
End Date 2014-06-01 2014-02-28 2013-08-30 2012-08-30

   
Records found: 144
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lovejoy Chandra D VP of Regulatory Affairs   •       –      –    2014-08-11 4 AS $7.00 $150,353 D/D (21,479) 6,250 11%     
   Lovejoy Chandra D VP of Regulatory Affairs   •       –      –    2014-08-11 4 OE $3.06 $76,016 D/D 21,479 27,729     -
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-04-10 4 OE $2.10 $56,976 D/D 22,560 34,282     -
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-04-09 4 AS $21.16 $21,160 D/D (1,000) 11,722 -68%     
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-03-21 4 AS $33.11 $264,880 D/D (8,000) 12,722 -73%     
   Ellis P Ron President and CEO   •       •      –    2014-03-10 4 OE $1.91 $152,800 D/D 80,000 204,586     -
   Ellis P Ron President and CEO   •       •      –    2014-02-21 4 GD $0.00 $0 D/D 2,400 124,586     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-14 4 AS $15.00 $90,000 D/D (6,000) 200,819     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-11 4 OE $1.91 $1,910 D/D 1,000 206,819     -
   Ritter Allen R VP of Manufacturing/CMC   •       –      –    2014-02-06 4 A $0.00 $0 D/D 5,000 20,722     -
   Leamon Christopher P Vice President of Research   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 17,573     -
   Low Philip S Chief Science Officer   •       •      –    2014-02-06 4 A $0.00 $0 D/D 7,500 205,819     -
   Lovejoy Chandra D VP of Regulatory Affairs   •       –      –    2014-02-06 4 A $0.00 $0 D/D 6,250 6,250     -
   Harper Scot VP of CLINICAL OPERATIONS   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 7,500     -
   Ellis P Ron President and CEO   •       •      –    2014-02-06 4 A $0.00 $0 D/D 22,500 51,654     -
   Meek David D. Chief Commercial Officer   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 7,500     -
   Taylor Beth Corporate Controller   •       –      –    2014-02-06 4 A $0.00 $0 D/D 5,425 7,147     -
   Sherman Michael A. Chief Financial Officer   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 80,798     -
   Brinkley Michael A. VP OF QUALITY   •       –      –    2014-02-06 4 A $0.00 $0 D/D 6,250 6,250     -
   Nguyen Binh VP of Medical Affairs   •       –      –    2014-02-06 4 A $0.00 $0 D/D 7,500 10,200     -
   Low Philip S Chief Science Officer   •       •      –    2014-01-14 4 OE $1.91 $1,910 D/D 1,000 198,319     -
   Low Philip S Chief Science Officer   •       •      –    2013-12-17 4 OE $1.91 $1,910 D/D 1,000 197,319     -
   Ellis P Ron President and CEO   •       •      –    2013-12-04 4 OE $1.91 $5,730 D/D 3,000 29,154     -
   Ellis P Ron President and CEO   •       •      –    2013-12-02 4 AS $12.00 $36,000 D/D (3,000) 26,154 54%     
   Low Philip S Chief Science Officer   •       •      –    2013-11-12 4 OE $1.91 $1,910 D/D 1,000 196,319     -

  144 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed